Brevitest Technologies

About:

Brevitest Technologies is a developer of a point-of-care medical device to assist enzyme immunoassays for early-stage detection of diseases.

Website: https://www.brevitest.com/

Top Investors: Texas A&M Innovation

Description:

Brevitest Technologies is a developer of a point-of-care medical device to assist enzyme immunoassays for early-stage detection of diseases. Its portable and automated analyzer performs enzyme-linked immunosorbent assays in less than ten minutes using customizable disposable cartridges suitable for detecting and quantifying peptides, proteins, antibodies, and hormones in biological samples that enable medical researchers to replace painful, time-consuming laboratory-based diagnostics and detect abnormalities in enzymes in a cost-effective manner.